Contact
Please use this form to send email to PR contact of this press release:
Open Monoclonal Technology and ARMO BioSciences Announce Anti-PD1 Antibody and OmniAb(TM) Platform License Agreement
TO:
Please use this form to send email to PR contact of this press release:
Open Monoclonal Technology and ARMO BioSciences Announce Anti-PD1 Antibody and OmniAb(TM) Platform License Agreement
TO: